Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Improving Intermediate Risk Management. MARK Study (MARK)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Preventive Services and Health Promotion Research Network
Information provided by (Responsible Party):
Jordi Gol i Gurina Foundation
ClinicalTrials.gov Identifier:
NCT01428934
First received: August 31, 2011
Last updated: September 8, 2016
Last verified: September 2016